Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorbtion with GM-CSF on alum

This publication has 20 references indexed in Scilit:

• Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans1Note: Nucleotide sequence data reported in this paper are available in the EMBL, GenBank™ and DDJB databases under the accession number X98619.1
  Molecular and Biochemical Parasitology, 1997
• Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
  Vaccine, 1996
• Controlling schistosomiasis by vaccination: A realistic option?
  Parasitology Today, 1995
• Identification of a major T cell immunogen in the anti‐schistosome response of adult residents in an area endemic for Schistosoma mansoni
  European Journal of Immunology, 1995
• Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma
  Nature, 1993
• Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area
  European Journal of Immunology, 1992
• The functional and immunological significance of some schistosome surface molecules
  Parasitology Today, 1991
• Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria.
  The Journal of Experimental Medicine, 1990
• The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase.
  The Journal of Experimental Medicine, 1989
• Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.
  The Journal of Experimental Medicine, 1988